Hiroo Imai

3PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 31, 2026
Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis.

|Apr 27, 2026
Association between antibiotic use, immune-related adverse events, and efficacy of immunotherapy in esophageal squamous cell carcinoma.

|Jul 30, 2021
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells.

Yoshifumi Kawamura, Ken Saijo, Hiroo Imai

Pageof 1

Frequent Collaborators

1 joint publications

Yoshifumi Kawamura

1 joint publications

Ken Saijo

1 joint publications

Chikashi Ishioka

1 joint publications

Iwao Sugitani